Adapted cognitive behavior therapy for obsessive-compulsive disorder with co-occurring autism spectrum disorder: A clinical effectiveness study.


Journal

Autism : the international journal of research and practice
ISSN: 1461-7005
Titre abrégé: Autism
Pays: England
ID NLM: 9713494

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 13 6 2019
medline: 1 12 2020
entrez: 13 6 2019
Statut: ppublish

Résumé

Obsessive-compulsive disorder and autism spectrum disorder commonly co-occur. Adapted cognitive behavior therapy for obsessive-compulsive disorder in adults with autism spectrum disorder has not previously been evaluated outside the United Kingdom. In this study, 19 adults with obsessive-compulsive disorder and autism spectrum disorder were treated using an adapted cognitive behavior therapy protocol that consisted of 20 sessions focused on exposure with response prevention. The primary outcome was the clinician-rated Yale-Brown Obsessive-Compulsive Scale. Participants were assessed up to 3 months after treatment. There were significant reductions on the Yale-Brown Obsessive-Compulsive Scale at post-treatment (d = 1.5), and improvements were sustained at follow-up (d = 1.2). Self-rated obsessive-compulsive disorder and depressive symptoms showed statistically significant reductions. Improvements in general functioning and quality of life were statistically non-significant. Three participants (16%) were responders at post-treatment and four (21%) were in remission from obsessive-compulsive disorder. At follow-up, three participants (16%) were responders and one (5%) was in full remission. Adapted cognitive behavior therapy for obsessive-compulsive disorder in adults with co-occurring autism spectrum disorder is associated with reductions in obsessive-compulsive symptoms and depressive symptoms. However, outcomes are modest; few patients were completely symptom free, and treatment engagement was low with few completed exposures and low adherence to homework assignments. We identify and discuss the need for further treatment refinement for this vulnerable group.

Identifiants

pubmed: 31187645
doi: 10.1177/1362361319856974
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-199

Auteurs

Oskar Flygare (O)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Stockholm County Council and M46, Karolinska University Hospital, Huddinge, Sweden.

Erik Andersson (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Helene Ringberg (H)

Stockholm Health Care Services, Stockholm County Council, CAP Research Centre, Stockholm, Sweden.

Anna-Clara Hellstadius (AC)

Department of Psychology, Stockholm University, Stockholm, Sweden.

Johan Edbacken (J)

Psykologpartners W&W AB, Stockholm, Sweden.

Jesper Enander (J)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Matti Dahl (M)

Stockholm Health Care Services, Stockholm County Council and M46, Karolinska University Hospital, Huddinge, Sweden.

Kristina Aspvall (K)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Stockholm County Council, CAP Research Centre, Stockholm, Sweden.

Indra Windh (I)

Stockholm Health Care Services, Stockholm County Council and M46, Karolinska University Hospital, Huddinge, Sweden.

Ailsa Russell (A)

Centre for Applied Autism Research, Department of Psychology, University of Bath, Bath, UK.

David Mataix-Cols (D)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Stockholm County Council, CAP Research Centre, Stockholm, Sweden.

Christian Rück (C)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Stockholm County Council and M46, Karolinska University Hospital, Huddinge, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH